104 results about "Anisodamine" patented technology

A veterinary medicine for treating the disease in digestive tract of animal and fowl is prepared from acetylmethaquine, anisodamine hydrochloride, sodium salicylate, and 4 Chinese-medicinal materials including pink plumepoppy herb, coptis root, etc.

The invention discloses a liver preservation solution which contains the following components in per 100ml: 7-8g of 1,6-fructose diphosptate, 1-2g of glutathione, 2-3g of allopurinol, 0.3-0.5g of traditional Chinese medicine ligustrazine, 8-12mg of traditional Chinese medicine anisodamine and the balance of Ringer's solution added to 100ml. Proved by a large number of experiments, the liver preservation solution has a statistical meaning compared with an experiment contrast group, and two treatment groups (a group of the invention and an American UW treatment group) do not have the statistical meaning. The invention provides an excellent guarantee for long-acting liver preservation, has simple prescription and saves production and inspection cost for production and clinical application.

The invention relates to an externally-used drug used for treating leucoderma skin disease, in particular to compound skin cream for treating leucoderma. The cream comprises, by weight, 0.20-0.50% of anisodamine, 0.10-0.50% of quercetin and 0.10-0.15% of betamethasone, the cream further comprises, by weight, 1.50-3.00% of dimethyl sulfoxide and 0.05-0.10% of 8-methoxypsoralen, and the cream further comprises oil phase raw materials, namely 15.00-25.00% of albolene, 8.00-15.00% of liquid paraffin, 5.00-9.00% of glycerin monostearate and 5.00-9.00% of octadecanol, and water phase raw materials, namely 0.50-1.20% of lauryl sodium sulfate, 5.00-10.00% of glycerinum, 0.05-0.10% of ethylparaben and 5.00-10.00% of propylene glycol; the cream further comprises 1.00-2.50% of hydrochloric acid and purified water, and the pH value ranges from 5.5 to 6.5. According to the compound skin cream for treating leucoderma, the formula is reasonable, the technique is feasible, and the cream has the advantages of being great in stability, good in effect and free of irritation.

The invention discloses a wet compressing preparation with the functions of resisting skin flap infection and promoting healing and the application thereof. The wet compressing preparation with the functions of resisting skin flap infection and promoting healing is characterized in that the raw materials comprise ligustrazine, anisodamine and normal saline, and the weight proportion of the ligustrazine, the anisodamine and the normal saline is 25-35:5-15:15-20; the preparation method of the wet compressing preparation comprises the steps that according to the weight proportion, the ligustrazine, the anisodamine and the normal saline are placed upside down in small square gauze after being mixed and dissolved thoroughly, and accordingly the wet compressing preparation is obtained. The wet compressing preparation has the advantages of enabling affected part microcirculation to be reestablished or improved, promoting blood circulation, increasing fibroblast cells, being conductive to forming wound surface growth factors, promoting growth of granulation tissue, enabling wound surfaces to be healed gradually, avoiding surgery, and relieving the pain of a patient.

The invention discloses a topical drug composite, and the formula comprises: by weight, 15-20 parts of rhizoma coptidis, 15-50 parts of radix scutellariae, 20-30 parts of lithospermum, 15-25 parts of safflower carthamus, 15-20 parts of myrrh, 15-50 parts of raw rhubarb, 50-100 parts of pseudo-ginseng, 15-50 parts of polygonum cuspidatum, 40-70 parts of zinc oxide, 0.8 part of anisodamine, 150 parts of borneol and 320-380 parts of sesame oil. The invention further discloses application of the topical drug composite in the preparation of drugs treating skin injury which comprises skin burn, skin scald, skin ambustion, skin lesions caused by radiation and chemotherapy, bedsore, and skin fester caused by other reasons.

The invention discloses a method for separating anisodamine and / or tropic acid mixed enantiomer. The method has the advantages that the anisodamine and tropic acid enantiomers can be respectively separated from a racemization anisodamine and tropic acid mixture; the structural formula is shown in formulas I to VI; the formulas I to VI are shown in the description. The method is a capillary electrophoresis method, and comprises the following steps that (1) an electrophoresis buffer solution contains a chiral resolution agent, and the chiral resolution agent is selected from a mixture of sulfobutyl-beta-cyclodextrin, and / or sulfobutyl-beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin; (2) the separation voltage is -8kV to -18kV.

The invention discloses a western medicine composition for preventing and treating scalds. The western medicine composition is prepared from, by weight, 1-15 parts of antibiotic, 1-7 parts of anisodamine, 2-10 parts of corticosteroid medicine, 20-50 parts of superoxide dismutase, 1-7 parts of metronidazole, 2-10 parts of vitamin B and 4-20 parts of vitamin E. The raw materials are easy to obtain, the western medicine composition is low in cost and easy to prepare, has the functions of relieving pain, diminishing inflammation and promoting tissue regeneration, and is remarkable in effect and short in effective time, scalds can be cured generally within one week, skin can recover, no scars or side effects are generated, and pain of long-time treatment is avoided.

The invention discloses a topical drug composite, and the formula comprises: by weight, 15-20 parts of rhizoma coptidis, 15-50 parts of radix scutellariae, 20-30 parts of lithospermum, 15-25 parts of safflower carthamus, 15-20 parts of myrrh, 15-50 parts of raw rhubarb, 50-100 parts of pseudo-ginseng, 15-50 parts of polygonum cuspidatum, 40-70 parts of zinc oxide, 0.8 part of anisodamine, 150 parts of borneol and 320-380 parts of sesame oil. The invention further discloses application of the topical drug composite in the preparation of drugs treating skin injury which comprises skin burn, skin scald, skin ambustion, skin lesions caused by radiation and chemotherapy, bedsore, and skin fester caused by other reasons.

The invention discloses application of atropa-belladonna ornithine decarboxylase to cultivating high-yield hyoscyamine and anisodamine atropa-belladonna varieties. The amino acid sequence coded by theatropa-belladonna ornithine decarboxylase is shown as SEQ ID NO.12, and as the ornithine decarboxylase is over expressed in atropa belladonna, rooting of the atropa belladonna can be improved, and the content of putrescine, N-methyl putrescine and TAs in plants can be increased; by researching AbODC, functions of the AbODC in polyamine and tropane-alkaloid biosynthesis are definite, understandingof biosynthetic pathways of tropane alkaloids can be deepened, and the AbODC has important theoretical value; related results of researching also indicate that the AbODC has the important applicationvalue in the aspects of improving the TAs biosynthetic pathways with a metabolic engineering technology and increasing the TAs content.

Disclosed is an oral antidiarrheal powder for treating diarrhea occurring on infants, which is composed by the method that 2.5 portions to 3.12 portions of indomethacin, 1 portion to 1.25 portions of anisodamine, 2.5 portions to 3.12 portions of chlorpromazine and 992.51 portions to 994 portions of glucose powder are well mixed to reach enough amount together with the glucose powder with the equivalently increasing method, and are split charged in each packet for 1000 mg. Based on the modern medical theories, the invention is a compound oral administration preparation, which has the advantages of scientific and reasonable composing prescriptions,stable formulation,convenient using in clinic, definite pharmacological effects, fast symptom controlling, short course of treatment, little side-effect, sweet taste, small taken dosage, convenience and safety, and thus the invention is a safe and effective auxiliary therapy reagent for treating various diarrheas occurring on infants, particularly the diarrheas in spring and autumn. With low price, fast effect, short treatment cycle and good therapeutic effect whether for the infectious diarrhea or the non-infectious diarrhea, the invention is an effective preparation for treating diarrhea in clinic.